With increasing temperature above 38,5 ° C more than 1% of the vaccinees or overt local reactions (swelling of the soft tissue with a diameter greater than 5 cm; infiltrates diameter greater than 2 cm) is more than 4% of vaccinees, and the development of severe complications post-vaccination, vaccinated the preparation of this series is discontinued.
Persons who have had acute infectious diseases are vaccinated not earlier than 1 month after clinical recovery. In milder forms of respiratory disease (rhinitis, slight hyperemia pharynx etc.) grafting allowed 2 weeks after recovery.
Patients with chronic diseases are vaccinated not earlier than 1 month after reaching a stable remission.
Patients with allergic diseases are vaccinated 2-4 weeks after the end of the exacerbation, while stable manifestations of the disease (localized skin conditions, hidden bronchospasm, etc.) are not contraindications to vaccination, which can be performed against the background of appropriate therapy.
Children born with a weight less than 2 kg are vaccinated under normal physical and psychomotor development; lag in weight is not a basis for postponing vaccination.
Immunodeficiency, HIV infection, as well as supporting course therapy, including steroid hormones and psychopharmaceuticals, are also not contraindications to vaccination.
In order to identify contraindications, the doctor (paramedic assistant of the feldsher-midwife station) on the day of vaccination is conducting a survey of parents and examining the vaccinated with mandatory thermometry. Persons temporarily released from vaccination should be monitored and accounted for and promptly vaccinated.
Note 1. Children with contraindications to the use of DTP vaccine, as well as children who have recovered whooping cough, can be vaccinated with ADS-M-anatoxin in accordance with the instruction for its use.
Note 2. With the development of a previous general DTP vaccine or a general or local reaction or complications, proceed as follows. If the child received one vaccination, the vaccination can be continued with ADS-M-anatoxin, which is administered once with a dose of 0.5 ml not earlier than 3 months.If the child is vaccinated twice, the vaccination course against diphtheria and tetanus is considered complete. In both cases, the first revaccination is performed with ADS-M-anatoxin 9-12 months after the last inoculation with a single dose of 0.5 ml. If complications occurred after the third vaccination with DTP vaccine, a first booster vaccination carried Td toxoid in 12-18 months single dose of 0.5 ml. Subsequent revaccinations are performed at 7, at 14 and every subsequent 10 years with ADS-M-anatoxin once with 0.5 ml dose.